{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:17:14Z","timestamp":1790471834363,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jaci.2015.09.059","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T10:46:20Z","timestamp":1452163580000},"page":"1863-1871.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3"],"prefix":"10.1016","volume":"137","author":[{"given":"Avanti","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Yeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair M.","family":"Gilfillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calman","family":"Prussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S.","family":"Kirshenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Beaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2015.09.059_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/08830189809042997","article-title":"Interleukin 6 and its receptor: ten years later","volume":"16","author":"Hirano","year":"1998","journal-title":"Intern Rev Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20110340","article-title":"IL-6\/IL-6 receptor system and its role in physiological and pathological conditions","volume":"122","author":"Mihara","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jaci.2015.09.059_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clim.2005.01.011","article-title":"IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis","volume":"115","author":"Brockow","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib4","article-title":"Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression","author":"Mayado","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2015.09.059_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1346-8138.2001.tb00126.x","article-title":"Acute urticaria with elevated circulating\u00a0interleukin-6 is resistant to anti-histamine treatment","volume":"28","author":"Fujii","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2015.09.059_bib6","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1365-2222.2011.03789.x","article-title":"Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients","volume":"41","author":"Kasperska-Zajac","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2015.09.059_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/thx.2010.136523","article-title":"Sputum IL-6 concentrations in severe asthma and its relationship with FEV1","volume":"66","author":"Morjaria","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2015.09.059_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V94.2.496","article-title":"Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34+ cord blood cells","volume":"94","author":"Kinoshita","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.09.059_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1523-1747.2003.12126.x","article-title":"Interleukin-6 enhances whereas tumor necrosis factor \u03b1 and interferons inhibit integrin expression and adhesion of human mast cells to extracellular matrix proteins","volume":"120","author":"Schoeler","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2015.09.059_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1600-0463.2009.02518.x","article-title":"IL-6, but not IL-4, stimulates chemokinesis and TNF stimulates chemotaxis of tissue mast cells: involvement of both mitogen-activated protein kinases and phosphatidylinositol 3-kinase signalling pathways","volume":"117","author":"Misiak-Tloczek","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.jaci.2015.09.059_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2172-9-2","article-title":"IgE alone promotes human lung mast cell\u00a0survival through the autocrine production of IL-6","volume":"9","author":"Cruse","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib12","first-page":"105","article-title":"Growth of human mast cells from bone marrow and peripheral blood-derived CD34+ pluripotent progenitor cells","volume":"315","author":"Kirshenbaum","year":"2006","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaci.2015.09.059_bib13","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1365-2222.2007.02778.x","article-title":"A protocol for generating high numbers of mature and functional human mast cells from peripheral blood","volume":"37","author":"Lappalainen","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2015.09.059_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/jir.2005.25.241","article-title":"IL-6 transsignaling: the in\u00a0vivo consequences","volume":"25","author":"Jones","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jaci.2015.09.059_bib15","doi-asserted-by":"crossref","first-page":"14804","DOI":"10.1074\/jbc.M111.229393","article-title":"Species\u00a0specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding","volume":"286","author":"Garbers","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.09.059_bib16","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1126\/science.1083901","article-title":"Hexameric structure and assembly of the interleukin-6\/IL-6 \u03b1-receptor\/gp130 complex","volume":"300","author":"Boulanger","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaci.2015.09.059_bib17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/j.1460-2075.1995.tb07128.x","article-title":"A major role for the protein tyrosine kinase JAK1 in the JAK\/STAT signal transduction pathway in response to interleukin-6","volume":"14","author":"Guschin","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2015.09.059_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2015.09.059_bib19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1357-2725(98)00067-3","article-title":"SOCS: suppressors of cytokine signalling","volume":"30","author":"Starr","year":"1998","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jaci.2015.09.059_bib20","first-page":"13","article-title":"Synergy of stem cell factor and other cytokines in mast cell development","author":"Nakahata","year":"1995","journal-title":"Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. Raven Press, NY"},{"key":"10.1016\/j.jaci.2015.09.059_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4049\/jimmunol.157.1.343","article-title":"Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells","volume":"157","author":"Saito","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/978-1-4419-9533-9_12","article-title":"Mast cell proteases as protective and inflammatory mediators","volume":"716","author":"Caughey","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2015.09.059_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-065X.2007.00525.x","article-title":"Protease-proteoglycan complexes of mouse and human mast cells and importance of their \u00e1-tryptase-heparin complexes in inflammation and innate immunity","volume":"217","author":"Stevens","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2015.09.059_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.190.2.267","article-title":"T Helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in\u00a0vitro","volume":"190","author":"Ochi","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.09.059_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/cyto.2002.2010","article-title":"IL-6 enhances IgE-dependent histamine release from human peripheral blood-derived cultured mast cells","volume":"20","author":"Kikuchi","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2015.09.059_bib26","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-02-0631","article-title":"Kit and Fc\u03b5RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells","volume":"104","author":"Hundley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.09.059_bib27","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/eji.201243214","article-title":"Prevention of F-actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells","volume":"43","author":"Smrz","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.smim.2013.11.002","article-title":"Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities","volume":"26","author":"Scheller","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1386207053258488","article-title":"Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules","volume":"8","author":"Ludwig","year":"2005","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1016\/j.jaci.2015.09.059_bib30","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","article-title":"The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion","volume":"102","author":"Hundhausen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.09.059_bib31","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2015.09.059_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1615\/CritRevImmunol.v31.i6.30","article-title":"Regulation of mast cell responses in health and disease","volume":"31","author":"Gilfillan","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1615\/CritRevImmunol.v29.i2.40","article-title":"Regulation of Ca2+ signaling with particular focus on mast cells","volume":"29","author":"Ma","year":"2009","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib34","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1101\/gad.1553707","article-title":"Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF\u03baB","volume":"21","author":"Yang","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaci.2015.09.059_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.smim.2013.12.004","article-title":"Inhibition of IL-6 family cytokines by SOCS3","volume":"26","author":"Babon","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib36","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/carcin\/bgs214","article-title":"IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer","volume":"33","author":"Li","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaci.2015.09.059_bib37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.gastro.2006.10.037","article-title":"Sustained IL-6\/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing","volume":"132","author":"Isomoto","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2015.09.059_bib38","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3324\/haematol.13043","article-title":"Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders","volume":"93","author":"Fourouclas","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2015.09.059_bib39","doi-asserted-by":"crossref","first-page":"14133","DOI":"10.1073\/pnas.2232790100","article-title":"SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer","volume":"100","author":"He","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2015.09.059_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00401-011-0832-0","article-title":"SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation","volume":"122","author":"Lindemann","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jaci.2015.09.059_bib41","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1038\/sj.onc.1208788","article-title":"Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK\/STAT and FAK signalings in human hepatocellular carcinoma","volume":"24","author":"Niwa","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jaci.2015.09.059_bib42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/pros.21245","article-title":"Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior","volume":"71","author":"Pierconti","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.jaci.2015.09.059_bib43","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1038\/sj.onc.1207787","article-title":"Differential hypermethylation of SOCS genes in ovarian and breast carcinomas","volume":"23","author":"Sutherland","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jaci.2015.09.059_bib44","first-page":"689","article-title":"Methylation status of the SOCS3 gene in human malignant melanomas","volume":"30","author":"Tokita","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jaci.2015.09.059_bib45","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1038\/sj.onc.1208818","article-title":"SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition","volume":"24","author":"Weber","year":"2005","journal-title":"Oncogene"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2015.09.059_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000167859","article-title":"Epigenetic alterations in cholangiocarcinoma-sustained IL-6\/STAT3 signaling in cholangio- carcinoma due to SOCS3 epigenetic silencing","volume":"79","author":"Isomoto","year":"2009","journal-title":"Digestion"},{"key":"10.1016\/j.jaci.2015.09.059_bib47","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/gene.2010.35","article-title":"Mast cell homeostasis and the JAK-STAT pathway","volume":"11","author":"Morales","year":"2010","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaci.2015.09.059_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2012.00020","article-title":"SOCS, inflammation, and autoimmunity","volume":"3","author":"Yoshimura","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib50","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.22999","article-title":"Interleukin-6 and its receptor in cancer: implications for translational therapeutics","volume":"110","author":"Hong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2015.09.059_bib51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000315946","article-title":"Mastocytosis","volume":"95","author":"Brockow","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaci.2015.09.059_bib52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1189\/jlb.0411209","article-title":"IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling","volume":"91","author":"Traum","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2015.09.059_bib53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/path.1780","article-title":"c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases","volume":"206","author":"Edwards","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.jaci.2015.09.059_bib54","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2015.09.059_bib55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.gene.6364120","article-title":"Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced","volume":"5","author":"Galicia","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaci.2015.09.059_bib56","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bbadis.2014.05.018","article-title":"The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases","volume":"1842","author":"Garbers","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2015.09.059_bib57","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2013.01.057","article-title":"A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis","volume":"132","author":"Esparza-Gordillo","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bib58","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.bjc.6605827","article-title":"Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer","volume":"103","author":"Okugawa","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaci.2015.09.059_bib59","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1158\/1078-0432.CCR-07-5017","article-title":"Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma","volume":"14","author":"Egler","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2015.09.059_bib60","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/rheumatology\/kel154","article-title":"Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor","volume":"45","author":"Peake","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2015.09.059_bibE1","first-page":"105","article-title":"Growth of human mast cells from bone marrow and peripheral blood-derived CD34+ pluripotent progenitor cells","volume":"315","author":"Kirshenbaum","year":"2006","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaci.2015.09.059_bibE2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(02)00343-0","article-title":"Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma\/leukemia; activation following aggregation of FceRI or FcgRI","volume":"27","author":"Kirshenbaum","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2015.09.059_bibE3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2172-9-45","article-title":"Effect of lipopolysaccharide (LPS) and peptidoglycan (PGN) on human mast cell numbers, cytokine production, and protease composition","volume":"9","author":"Kirshenbaum","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bibE4","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0738s91","article-title":"Measuring mast cell mediator release","author":"Kuehn","year":"2010","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaci.2015.09.059_bibE5","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-02-0631","article-title":"Kit and FceRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells","volume":"104","author":"Hundley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.09.059_bibE6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-1759(02)00210-7","article-title":"Determination of protein phosphorylation in FceRI-activated human mast cells by immunoblot analysis requires protein extraction under denaturing conditions","volume":"268","author":"Tkaczyk","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2015.09.059_bibE7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/carcin\/bgs214","article-title":"IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer","volume":"33","author":"Li","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaci.2015.09.059_bibE8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1386207053258488","article-title":"Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules","volume":"8","author":"Ludwig","year":"2005","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1016\/j.jaci.2015.09.059_bibE9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","article-title":"The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion","volume":"102","author":"Hundhausen","year":"2003","journal-title":"Blood"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167491501739X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167491501739X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:58:48Z","timestamp":1758790728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167491501739X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S009167491501739X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2015.09.059","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2015.09.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier, Inc. on behalf of American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}